Further delineation of HIDEA syndrome

Am J Med Genet A. 2020 Dec;182(12):2999-3006. doi: 10.1002/ajmg.a.61885. Epub 2020 Sep 23.

Abstract

Recently, the genetic cause of HIDEA syndrome (hypotonia, hypoventilation, intellectual disability, dysautonomia, epilepsy, and eye abnormalities) was identified as biallelic pathogenic variants in P4HTM, which encodes an atypical member of the prolyl 4-hydroxylases (P4Hs) family of enzymes. We report seven patients from four new families in whom HIDEA was only diagnosed after whole-exome sequencing (WES) revealed novel disease-causing variants in P4HTM. We note the variable phenotypic expressivity of the syndrome except for cognitive impairment/developmental delay, and hypotonia, which seem to be consistent findings. One patient only presented with hypotonia, developmental delay, and abnormal eye movements, which highlights the challenge in diagnosing milder cases with this new syndrome. Other notable features include mild facial dysmorphism, obesity, and brain dysmyelination and atrophy. We conclude that HIDEA is a highly variable syndrome and suspect that a large fraction of patients will be diagnosed via reverse phenotyping after recessive P4HTM variants are identified by agnostic genomic sequencing assays.

Keywords: HIDEA syndrome; P4HTM; developmental delay; hypoventilation; intellectual disability; reverse phenotyping.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Child, Preschool
  • Developmental Disabilities
  • Epilepsy / genetics
  • Epilepsy / pathology*
  • Eye Abnormalities / genetics
  • Eye Abnormalities / pathology*
  • Female
  • Humans
  • Hypoventilation / genetics
  • Hypoventilation / pathology*
  • Intellectual Disability / genetics
  • Intellectual Disability / pathology*
  • Male
  • Muscle Hypotonia / genetics
  • Muscle Hypotonia / pathology*
  • Mutation*
  • Pedigree
  • Phenotype
  • Prolyl Hydroxylases / genetics*
  • Syndrome

Substances

  • Prolyl Hydroxylases